Financial Fitness Check: Examining Semler Scientific Inc (SMLR)’s Key Ratios

Kiel Thompson

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

In the latest session, Semler Scientific Inc (NASDAQ: SMLR) closed at $24.61 down -5.29% from its previous closing price of $25.99. In other words, the price has decreased by -$5.29 from its previous closing price. On the day, 0.57 million shares were traded. SMLR stock price reached its highest trading level at $26.08 during the session, while it also had its lowest trading level at $24.33.

Ratios:

For a deeper understanding of Semler Scientific Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 39.60. For the most recent quarter (mrq), Quick Ratio is recorded 0.58 and its Current Ratio is at 0.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On July 08, 2025, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $101.

B. Riley Securities Downgraded its Buy to Neutral on November 02, 2022, whereas the target price for the stock was revised from $60 to $45.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 25 ’25 when Murphy-Chutorian Douglas sold 28,604 shares for $30.54 per share. The transaction valued at 873,566 led to the insider holds 31,396 shares of the business.

Douglas Murphy-Chutorian bought 60,000 shares of SMLR for $1,847,400 on Aug 25 ’25. On Dec 10 ’24, another insider, Murphy-Chutorian Douglas, who serves as the CEO of the company, sold 75,000 shares for $60.12 each. As a result, the insider received 4,508,683 and left with 65,083 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMLR now has a Market Capitalization of 372725120 and an Enterprise Value of 447214528. As of this moment, Semler’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.22 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 10.406 whereas that against EBITDA is 82.741.

Stock Price History:

The Beta on a monthly basis for SMLR is 1.43, which has changed by -0.19768578 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, SMLR has reached a high of $81.56, while it has fallen to a 52-week low of $21.84. The 50-Day Moving Average of the stock is -12.97%, while the 200-Day Moving Average is calculated to be -33.22%.

Shares Statistics:

For the past three months, SMLR has traded an average of 1.01M shares per day and 1135080 over the past ten days. A total of 13.69M shares are outstanding, with a floating share count of 13.30M. Insiders hold about 12.17% of the company’s shares, while institutions hold 73.45% stake in the company. Shares short for SMLR as of 1760486400 were 3904402 with a Short Ratio of 3.88, compared to 1757894400 on 2590793. Therefore, it implies a Short% of Shares Outstanding of 3904402 and a Short% of Float of 29.2.

Earnings Estimates

A detailed examination of Semler Scientific Inc (SMLR) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.2, with high estimates of $0.04 and low estimates of -$0.45.

Analysts are recommending an EPS of between -$3.66 and -$3.66 for the fiscal current year, implying an average EPS of -$3.66. EPS for the following year is -$0.75, with 2.0 analysts recommending between $0.08 and -$1.58.

Revenue Estimates

A total of 3 analysts believe the company’s revenue will be $7.87M this quarter.It ranges from a high estimate of $8.38M to a low estimate of $6.92M. As of. The current estimate, Semler Scientific Inc’s year-ago sales were $13.51MFor the next quarter, 3 analysts are estimating revenue of $6.66M. There is a high estimate of $8.46M for the next quarter, whereas the lowest estimate is $3.41M. Based on 3 analysts’ estimates, the company’s revenue will be $27.1M in the next fiscal year. The high estimate is $34.72M and the low estimate is $14.18M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.